Comparison of Humoral Immune Responses to Epstein-Barr Virus and Kaposi’s Sarcoma–Associated Herpesvirus Using a Viral Proteome Microarray
Author(s) -
Dasheng Zheng,
Jun Wan,
Yong Gu Cho,
Leyao Wang,
Chuang-Jiun Chiou,
Shweta Pai,
Crystal Woodard,
Jian Zhu,
Gangling Liao,
Otoniel Martı́nez-Maza,
Qian Jiang,
Heng Zhu,
Gary S. Hayward,
Richard F. Ambinder,
S. Diane Hayward
Publication year - 2011
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1093/infdis/jir645
Subject(s) - virology , biology , immune system , antigen , epstein–barr virus , virus , lytic cycle , kaposi's sarcoma associated herpesvirus , antibody , immunology , primary effusion lymphoma , gammaherpesvirinae , herpesviridae , viral disease
Epstein-Barr virus (EBV) is a ubiquitous herpesvirus, and Kaposi's sarcoma-associated herpesvirus (KSHV) has a restricted seroprevalence. Both viruses are associated with malignancies that have an increased frequency in individuals who are coinfected with human immunodeficiency virus type 1 (HIV-1).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom